Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by BearDownAZon Apr 15, 2015 1:58pm
362 Views
Post# 23632828

Lesson from ESPR

Lesson from ESPRI had a very small position (100 shares) of ESPR that I bought at ~$14 USD. After one of their several Phase II announcments, it went up to ~$20 and I thought thiings would level off here so I sold to make a few hundred bucks (not much, but some play money). Well, in the next 3-4 months it climbed and climbed and climbed to where it is today ~$100 USD (market cap ~2 billion). I believe ESPR will be successful in Phase III. I believe RVX will be successful in Phase III. I learned my lesson to be careful to not sell and be out of the game if you truly believe in something. All it takes is one NR and RVX might fly. Very doubtful it will get to market cap of 2 billion like ESPR in the near short term, but based on what happened with ESPR, you never know. 
Bullboard Posts